An orally administered multitarget tyrosine kinase inhibitor, SU11248, is a novel potent inhibitor of thyroid oncogenic RET/papillary thyroid cancer kinases.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples